Navigation Links
Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide
Date:8/11/2008

m. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These and other important factors, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended June 30, 2007, as well as the Company's subsequent filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this press release are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, futur
'/>"/>

SOURCE Perrigo Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Perrigo Vice Chair Mori Arkin To Retire After 30 Years of Service
2. Perrigo Company to Host Analyst Meeting on September 18, 2007
3. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
4. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
5. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
6. Perrigo Company Will Release First Quarter Fiscal 2008 Results on November 1, 2007
7. Perrigo Company Announces Dividend Increase
8. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
9. Perrigo Company to Present at The 26th Annual JPMorgan Healthcare Conference
10. Perrigo Acquires UK OTC Store Brand Supplier
11. Perrigo Company Authorizes Continuation of Share Repurchase Program and Announces Quarterly Dividend

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...RNewswire/ -- The development of University Medica...d a milestone today with a "topping out" ceremony,...n at the new hospital that will replace University... http://www.newscom.com/cgi-bin/prnh/20091203/NY2...ers, tradition in which a steel beam carrying an e...
(Date:12/3/2009)...wire-Asia/ -- Long believed to provide a variety o...nt ingredients in global,cuisine, has seen increas... The timing of this ginger demand increase coin...e pressures in a way that has speculators wonderin...ysteria over garlic. Garlic, also,believed to have...
(Date:12/3/2009)...e-USNewswire/ -- The American Association of Homes...enate for passing Sen. Michael Bennet,s (D-Colo.) ...uaranteed benefits, and strengthens Medicare by ke...silver tsunami of retiring baby boomers fast appro...slation currently before Congress to address Medic...
(Date:12/3/2009)...ylureas, but each patient will be different, exper...ews) -- A class of drugs still taken by millions ...a higher risk of dying and heart failure than the ... Sulfonylureas, long a mainstay of diabetes treatm... of oral anti-diabetes drugs, but doctors said the...
(Date:12/3/2009)...arning of diabetes, cardiovascular disease, resear...y News) -- Pregnant women who develop gestational ...d risk for metabolic syndrome three months after t... glucose intolerance is less severe than gestation... of factors (including high blood pressure, obesit...
Breaking Medicine News(10 mins):Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 3Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 4Health News:Ginger Prices Could Skyrocket on H1N1 Fears 2Health News:Diabetes Drugs Go Head-to-Head in Study 2Health News:Diabetes Drugs Go Head-to-Head in Study 3Health News:Blood Sugar Intolerance May Predict Postpartum Ills 2
...ing" may be more appropriate in men with low-risk ... with surgery or radiation therapy, according to a...Ann Arbor. The results of the study conducte...ed that watchful waiting or "expectant management"...
...syrup diet sweeping through Britain and promoted b...llowers lose a stone in 10 days.// All over t...Natural Tree Syrup flying off the shelves after po...s and costs about ?39.99 per liter. It is taken mi...
... glioma cancer cells that share many characteristi... of brain cancers by promoting tumor blood vessel/...e deadly cancers, a research team reported in the ...rsity, the researchers found that a small subset o...
...e bright sunshine on a warm autumn day does more t...y to produce huge amounts of vitamin D. Often call...ly a vitamin at all, but rather a versatile hormon...verts vitamin D produced in the skin into the acti...
... new study at the University of Michigan Depressio...epression are not getting// any treatment nor are ...gns of milder depression. In the latest issue ...equate treatment -- medication, talk therapy, or b...
...IDS epidemic would grow rapidly unless eight count... high-risk groups with better HIV prevention// mea...More than 5.5 million people are infected with HIV...e 16th International AIDS Conference in Toronto, C...
Other Medicine News:Health News:Watchful Waiting Effective for Low Risk Prostate Cancer 2Health News:Cancer Stem Cells Could Hold Key to Brain Tumor Therapy 2Health News:Sunshine Vitamin for Prostate Cancer 2Health News:No therapy for most of the pregnant women with depression 2Health News:No therapy for most of the pregnant women with depression 3Health News:No therapy for most of the pregnant women with depression 4Health News:India Urged to Take Stringent Measures to Combat AIDS 2Health News:India Urged to Take Stringent Measures to Combat AIDS 3
(Date:12/3/2009)...NEW YORK, Dec. 3 Guidepoint Globa...nounced the launch of their Sleep Apnea Tracker, a...nd projects trends and market share in the worldwi...ker captures actual patient usage for 87 different... from 15 different equipment providers going back ...
(Date:12/3/2009)..., DOYLESTOWN, Pa., Dec. 3 /PRNewswire-FirstCall/...rporation, (Nasdaq: QGLY ) www.quigleyco.com an...valuation of its opportunities to develop prescrip...uded that it is in its best interests to focus pri... may include but are not limited to its Cold-EEZE&...
(Date:12/3/2009)..., FORT WORTH, Texas, Dec. 3 /PRNewswire-First...C Bulletin Board: WNDM), a rapidly growing provide...n agreement with the Health Industry Representativ...ndependent sales and marketing representative to m...ct within the U.S. ,, HIRA will market and sel...
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Cooper Martin Unveils Innovative Stylish Recovery Clothing for Those with Limited Mobility 48188 1Cooper Martin Unveils Innovative Stylish Recovery Clothing for Those with Limited Mobility 48188 2Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 1Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 2Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 3Researchers work to boost effectiveness of the flu vaccine 48184 1Researchers work to boost effectiveness of the flu vaccine 48184 2Researchers work to boost effectiveness of the flu vaccine 48184 3
...rnal of Clinical Lipidology publishes largest stud.../simvastatin to statin therapies using FDA databas...creased cancer risk with ezetimibe mono and ezetim...o cancer rates of other powerful lipid-lowering st...ical Center lipid and health policy experts, was p...
...ERUSALEM, March 25 Oramed Pharmaceuticals,Inc. (O...per of oral delivery,systems, announced today that...the study, entitled, "Open Label Study to Assess t...cs (PD) of Oral Insulin Formulations,in Subjects w...nnual American,Diabetes Association,s Scientific S...
Other Medicine Technology:Ezetimibe and Ezetimibe/Simvastatin Combo Pose No Increased Cancer Risk, Study Shows 2Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA) 2
Optima III Noninsulated Allis Tooth Grasper, without ratchet
Optima III Noninsulated Duck-Bill Grasper, with ratchet
Uninsulated locking handle
Snap-In Snap-Out®-II Single Ring Handle, ratcheted, noninsulated handle, insulated shaft
Medicine Products: